Free and total circulating magnesium following glucagon injection in humans.

Rossier MC, Truttmann AC, von Vigier RO, Stoffel PB, Bianchetti MG

Magnesium research1 Sept 1999Cited by 2 (Europe PMC)

PMID10488473PepBankPUB-10488473

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. 5 results from people.

01HumanNon-randomized trialEfficacy outcome
In healthy humans, glucagon raised glucose at 5, 10, 20 and 30 min compared with a control study.
In plain wordsIn healthy people, glucagon raised blood glucose compared with a control study.
Peptide
Glucagon
Outcome
IncreaseGlucose
Study
n = 11
Comparator
Control study
Outcome group
Glycemic control · Metabolic and weight
Studied dose
1 mg bolus · intravenousAs given in this study (human).
Source sentences
Summary
As compared with a control study, intravenous injection of a bolus of 1 mg of glucagon was associated with the expected raised glucose (at 5, 10, 20 and 30 min) and with decreased potassium (at 20 and 30 min) and inorganic phosphate (at 20 and 30 min) levels.
1 context sentence(design, population, supporting numbers)
Summary · context
The effects of exogenous glucagon injection on circulating total and ionized magnesium were investigated in 11 healthy humans (five females and six males, aged between 21 and 30, median 26 years).
Report a problemFND-1048847301
02HumanNon-randomized trialEfficacy outcome
In healthy humans, glucagon decreased potassium at 20 and 30 min compared with a control study.
In plain wordsIn healthy people, glucagon lowered potassium compared with a control study.
Peptide
Glucagon
Outcome
DecreasePotassium
Study
n = 11
Comparator
Control study
Outcome group
Electrolytes · Metabolic and weight
Studied dose
1 mg bolus · intravenousAs given in this study (human).
Source sentences
Summary
As compared with a control study, intravenous injection of a bolus of 1 mg of glucagon was associated with the expected raised glucose (at 5, 10, 20 and 30 min) and with decreased potassium (at 20 and 30 min) and inorganic phosphate (at 20 and 30 min) levels.
1 context sentence(design, population, supporting numbers)
Summary · context
The effects of exogenous glucagon injection on circulating total and ionized magnesium were investigated in 11 healthy humans (five females and six males, aged between 21 and 30, median 26 years).
Report a problemFND-1048847302
03HumanNon-randomized trialEfficacy outcome
In healthy humans, glucagon decreased inorganic phosphate at 20 and 30 min compared with a control study.
In plain wordsIn healthy people, glucagon lowered inorganic phosphate compared with a control study.
Peptide
Glucagon
Outcome
DecreaseInorganic phosphate
Study
n = 11
Comparator
Control study
Outcome group
Electrolytes · Metabolic and weight
Studied dose
1 mg bolus · intravenousAs given in this study (human).
Source sentences
Summary
As compared with a control study, intravenous injection of a bolus of 1 mg of glucagon was associated with the expected raised glucose (at 5, 10, 20 and 30 min) and with decreased potassium (at 20 and 30 min) and inorganic phosphate (at 20 and 30 min) levels.
1 context sentence(design, population, supporting numbers)
Summary · context
The effects of exogenous glucagon injection on circulating total and ionized magnesium were investigated in 11 healthy humans (five females and six males, aged between 21 and 30, median 26 years).
Report a problemFND-1048847303
04HumanNon-randomized trialEfficacy outcome
In healthy humans, plasma total magnesium did not change significantly after glucagon injection.
In plain wordsIn healthy people, total magnesium did not change significantly after glucagon injection.
Peptide
Glucagon
Outcome
No significant changeTotal magnesium
Study
n = 11
Outcome group
Electrolytes · Metabolic and weight
Studied dose
1 mg bolus · intravenousAs given in this study (human).
Source sentences
Summary
Intravenous glucagon was not followed by significant changes in plasma total and ionized magnesium.
1 context sentence(design, population, supporting numbers)
Summary · context
The effects of exogenous glucagon injection on circulating total and ionized magnesium were investigated in 11 healthy humans (five females and six males, aged between 21 and 30, median 26 years).
Report a problemFND-1048847304
05HumanNon-randomized trialEfficacy outcome
In healthy humans, plasma ionized magnesium did not change significantly after glucagon injection.
In plain wordsIn healthy people, ionized magnesium did not change significantly after glucagon injection.
Peptide
Glucagon
Outcome
No significant changeIonized magnesium
Study
n = 11
Outcome group
Electrolytes · Metabolic and weight
Studied dose
1 mg bolus · intravenousAs given in this study (human).
Source sentences
Summary
Intravenous glucagon was not followed by significant changes in plasma total and ionized magnesium.
1 context sentence(design, population, supporting numbers)
Summary · context
The effects of exogenous glucagon injection on circulating total and ionized magnesium were investigated in 11 healthy humans (five females and six males, aged between 21 and 30, median 26 years).
Report a problemFND-1048847305

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
28 Oct 2026, 02:03 UTC
Study results updated
Version 1
27 Oct 2026, 16:35 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

Journal Article

MeSH terms

PepBank is a research reference. Talk to a doctor before you use any peptide.